No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
-
Dose-Response Relationship, Drug
-
Double-Blind Method
-
Drug Administration Schedule
-
Female
-
Humans
-
Idiopathic Pulmonary Fibrosis / diagnosis
-
Idiopathic Pulmonary Fibrosis / drug therapy*
-
Idiopathic Pulmonary Fibrosis / mortality
-
Male
-
Middle Aged
-
Prognosis
-
Pyridones / administration & dosage*
-
Risk Assessment
-
Severity of Illness Index
-
Survival Rate
-
Time-to-Treatment*
-
Treatment Outcome
-
Vital Capacity / drug effects
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Pyridones
-
pirfenidone
Associated data
-
ClinicalTrials.gov/NCT00662038